Advances in physiology and biochemistry have provided fundamental insights into the role
of pulmonary surfactant in the pathogenesis and treatment of preterm infants with respiratory …

Pulmonary alveolar microlithiasis (PAM) is a rare disease characterised by the widespread
intra-alveolar accumulation of minute calculi called microliths. It is caused by mutation of the …

Pulmonary alveolar microlithiasis (PAM) is a rare genetic lung disease characterized by
calcifications within the alveoli. Mutations in the SLC34A2 gene, which encodes a type IIb …

The world of rare interstitial lung diseases (ILDs) is diverse and complex. Diagnosis and
therapy usually pose challenges. This review describes a selection of rare and ultrarare …

Pulmonary alveolar microlithiasis (PAM) is a rare hereditary lung disease in which calcium
phosphate deposits (calcospherites) accumulate in the distal airspaces. An Italian scientist …

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disease
characterized by the formation of calcium phosphate microliths in the alveoli. Mutations in …

Pulmonary alveolar microlithiasis is an autosomal recessive lung disease caused by a
deficiency in the pulmonary epithelial Npt2b sodium-phosphate co-transporter that results in …

Pulmonary alveolar microlithiasis (PAM) is a fascinating rare lung disease that is associated
with the accumulation of hydroxyapatite microliths within the lumen of the alveolar spaces. In …

Pulmonary alveolar microlithiasis is a rare diffuse lung disease characterised by deposition
of calcium phosphate within the alveolar airspaces. The disease is usually discovered from …

Pulmonary alveolar microlithiasis (PAM) is a rare parenchymal lung disease caused by
variants in the SCL34A2 gene and characterised by the accumulation of intra-alveolar …